Related references
Note: Only part of the references are listed.Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes-2016 (vol 39, pg S13, 2016)
DIABETES CARE (2016)
Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction
Aritz Lopategi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes - Biomarkers as a possible tool for early disease detection for rural screening
L. Maschirow et al.
CLINICAL BIOCHEMISTRY (2015)
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Ulrike Hostalek et al.
DRUGS (2015)
Metabolomic Profile Associated With Insulin Resistance and Conversion to Diabetes in the Insulin Resistance Atherosclerosis Study
Nicholette D. Palmer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes
Rodney A. Hayward et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Optimal Hemoglobin A1c Levels for Screening of Diabetes and Prediabetes in the Japanese Population
Masanori Shimodaira et al.
JOURNAL OF DIABETES RESEARCH (2015)
A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial (vol 10, e0138646, 2015)
Yuejun Liu et al.
PLOS ONE (2015)
Treatment of prediabetes
Mustafa Kanat et al.
WORLD JOURNAL OF DIABETES (2015)
Prediabetes diagnosis and treatment: A review
Nidhi Bansal
WORLD JOURNAL OF DIABETES (2015)
Prediabetes in Patients with Stroke or Transient Ischemic Attack: Prevalence, Risk and Clinical Management
Susanne Fonville et al.
CEREBROVASCULAR DISEASES (2014)
Diabetes Mellitus, Prediabetes, and Incidence of Subclinical Myocardial Damage
Elizabeth Selvin et al.
CIRCULATION (2014)
Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
Leigh Perreault et al.
DIABETES CARE (2014)
What are the pharmacotherapy options for treating prediabetes?
Giuseppe Daniele et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Lack of Racial Disparity in Incident Prediabetes and Glycemic Progression Among Black and White Offspring of Parents With Type 2 Diabetes: The Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) Study
Samuel Dagogo-Jack et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Prevalence and associations of diabetic retinopathy in a large cohort of prediabetic subjects: The Gutenberg Health Study
Julia Lamparter et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
BMI and waist circumference are associated with impaired glucose metabolism and type 2 diabetes in normal weight Chinese adults
Shengxu Li et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
Evidence That Multiple Defects in Lipid Regulation Occur before Hyperglycemia during the Prodrome of Type-2 Diabetes
Simon G. Anderson et al.
PLOS ONE (2014)
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
Guangwei Li et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Incretin-based therapies in prediabetes: Current evidence and future perspectives
Georgios S. Papaetis
WORLD JOURNAL OF DIABETES (2014)
Impaired retinal vasodilator responses in prediabetes and type 2 diabetes
Mary E. J. Lott et al.
ACTA OPHTHALMOLOGICA (2013)
Secular Changes in US Prediabetes Prevalence Defined by Hemoglobin A1c and Fasting Plasma Glucose National Health and Nutrition Examination Surveys, 1999-2010
Kai McKeever Bullard et al.
DIABETES CARE (2013)
Pathogenesis of Prediabetes: Role of the Liver in Isolated Fasting Hyperglycemia and Combined Fasting and Postprandial Hyperglycemia
Rita Basu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Monofilament insensitivity and small and large nerve fiber symptoms in impaired fasting glucose
Kelly R. Ylitalo et al.
PRIMARY CARE DIABETES (2013)
Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance
Mustafa Kanat et al.
DIABETES (2012)
Circulating Levels of TNF-α Are Associated with Impaired Glucose Tolerance, Increased Insulin Resistance, and Ethnicity: The Insulin Resistance Atherosclerosis Study
Nels C. Olson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Prediabetes: a high-risk state for diabetes development
Adam G. Tabak et al.
LANCET (2012)
OPINION Preventing diabetes mellitus in developing countries
Justin B. Echouffo-Tcheugui et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Metabolomic Prediction of Diabetes and Cardiovascular Risk
Samuel Dagogo-Jack
MEDICAL PRINCIPLES AND PRACTICE (2012)
Prediabetes as a Therapeutic Target
Omid Rad Pour et al.
CLINICAL CHEMISTRY (2011)
The Relationship Between β-Cell Function and Glycated Hemoglobin Results from the Veterans Administration Genetic Epidemiology Study
Mustafa Kanat et al.
DIABETES CARE (2011)
Globalization of Diabetes The role of diet, lifestyle, and genes
Frank B. Hu
DIABETES CARE (2011)
Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
Ebe D'Adamo et al.
DIABETES CARE (2011)
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
M. A. Nauck et al.
DIABETOLOGIA (2011)
Serum C-reactive protein level and prediabetes in two Asian populations
C. Sabanayagam et al.
DIABETOLOGIA (2011)
Metabolite profiles and the risk of developing diabetes
Thomas J. Wang et al.
NATURE MEDICINE (2011)
Neuropathy in prediabetes: does the clock start ticking early?
Nikolaos Papanas et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
Ralph A. DeFronzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pathogenesis of Insulin Resistance in Skeletal Muscle
Muhammad A. Abdul-Ghani et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
Bernard Zinman et al.
LANCET (2010)
Principles and Practice of Nonpharmacological Interventions to Reduce Cardiometabolic Risk
Samuel Dagogo-Jack et al.
MEDICAL PRINCIPLES AND PRACTICE (2010)
Full Accounting of Diabetes and Pre-Diabetes in the US Population in 1988-1994 and 2005-2006
Catherine C. Cowie et al.
DIABETES CARE (2009)
Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2)
A. Ramachandran et al.
DIABETOLOGIA (2009)
Glucoregulatory Physiology in Subjects with Low-Normal, High-Normal, or Impaired Fasting Glucose
Samuel Dagogo-Jack et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?
Leigh Perreault et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program
Kieren J. Mather et al.
DIABETES (2008)
Effect of a multifactorial intervention on mortality in type 2 diabetes
Peter Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis
Sayeeda Rahman et al.
DIABETES OBESITY & METABOLISM (2007)
Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians - Within-trial results of the Indian diabetes prevention programme (IDPP)
Ambady Ramachandran et al.
DIABETES CARE (2007)
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
H. C. Gerstein et al.
LANCET (2006)
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)
A Ramachandran et al.
DIABETOLOGIA (2006)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Five stages of evolving β-cell dysfunction during progression to diabetes
GC Weir et al.
DIABETES (2004)
XENical in the prevention of diabetes in obese subjects (XENDOS) study
JS Torgerson et al.
DIABETES CARE (2004)
Metabolic and molecular basis of insulin resistance
M Bajaj et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2003)
Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
JL Chiasson et al.
LANCET (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type a diabetes development
C Weyer et al.
DIABETES CARE (2001)
Share Paper
